Consistent with the greater apoptotic events, the combined treatment led to higher levels of cleaved PARP and cleaved Caspase-3 and Caspase-3/7 activity in the three ICC cell lines compared to the single-drug treatment alone (Fig. 2c, d). Here, CASP3 is linked to intrahepatic cholangiocarcinoma.